Mettler-Toledo International's EBIT per Share for the
three
months ended in Mar. 2026 was €9.64.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €47.09.
During the past 12 months, the average EBIT per Share Growth Rate of Mettler-Toledo International was 5.80% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 3.00% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 9.60% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 12.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Mettler-Toledo International's EBIT per Share or its related term are showing as below:
FRA:MTO'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 3 Med: 12.2 Max: 23.9
Current: 3
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Mettler-Toledo International was 23.90% per year. The lowest was 3.00% per year. And the median was 12.20% per year.
FRA:MTO's 3-Year EBIT Growth Rate is ranked worse than 63.69% of 168
companies
in the Medical Diagnostics & Research industry
Industry Median: 12.75
vs FRA:MTO: 3.00
Mettler-Toledo International (FRA:MTO) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Mettler-Toledo International EBIT per Share Related Terms
Mettler-Toledo International EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €47.09
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mettler-Toledo International (FRA:MTO) has a EBIT per Share of €47.09 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Mettler-Toledo International and its competitors. According to the industry distribution chart, Mettler-Toledo International ranks #107 out of 168 companies in the Medical Diagnostics & Research industry, placing it in the top 63.7%.
Is Mettler-Toledo International's EBIT per Share too high?
Mettler-Toledo International's current EBIT per Share is €47.09. Based on the distribution chart, Mettler-Toledo International ranks #107 out of 168 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Mettler-Toledo International has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mettler-Toledo International's EBIT per Share compare to ILMN and DGX?
According to the Medical Diagnostics & Research industry distribution chart, Mettler-Toledo International ranks #107 out of 168 companies for EBIT per Share. This places Mettler-Toledo International in the lower half of its industry. The industry median EBIT per Share is 12.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Diagnostics & Research company?
The median EBIT per Share among Medical Diagnostics & Research companies is 12.75, based on 168 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Mettler-Toledo International and its competitors. For the Medical Diagnostics & Research industry, the median EBIT per Share is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mettler-Toledo International's current EBIT per Share is €47.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mettler-Toledo International stock overvalued right now?
Based on GuruFocus' analysis, Mettler-Toledo International (FRA:MTO) is currently considered Fairly Valued. The stock's GF Value™ is €1,247.81, compared to a current price of €1,139.00 — trading 8.7% below its estimated fair value. The current EBIT per Share is €47.09. Mettler-Toledo International's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Mettler-Toledo International (FRA:MTO), the current EBIT per Share is €47.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mettler-Toledo International (FRA:MTO) Overvalued in 2026?
Based on GuruFocus' analysis, Mettler-Toledo International stock appears to be undervalued.
The current stock price of €1,139.00 is trading 8.7% below its estimated GF Value™ of €1,247.81.
GuruFocus considers Mettler-Toledo International to be Fairly Valued.
Key valuation signals for FRA:MTO:
EBIT per Share: €47.09
GF Value™: €1,247.81 vs. price of €1,139.00 (8.7% below fair value)
No single metric tells the full story. See the FRA:MTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.
93GF Score
Get the complete analysis for FRA:MTO
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MTO has been successfully added to your 
